BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 20973771)

  • 1. Impact of etanercept treatment on ultraviolet B-induced inflammation, cell cycle regulation and DNA damage.
    Gambichler T; Tigges C; Dith A; Skrygan M; Scola N; Altmeyer P; Kreuter A
    Br J Dermatol; 2011 Jan; 164(1):110-5. PubMed ID: 20973771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Etanercept therapy for psoriasis in a patient with numerous comorbidities.
    De Simone C; Carbone A; Caldarola G
    Am J Clin Dermatol; 2010; 11 Suppl 1():49-50. PubMed ID: 20586510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pilot study of etanercept treatment for pemphigus vulgaris.
    Fiorentino DF; Garcia MS; Rehmus W; Kimball AB
    Arch Dermatol; 2011 Jan; 147(1):117-8. PubMed ID: 21242406
    [No Abstract]   [Full Text] [Related]  

  • 4. Etanercept therapy for psoriasis in a patient with active pulmonary tuberculosis.
    Huo R; Romanelli P
    Am J Clin Dermatol; 2010; 11 Suppl 1():39-40. PubMed ID: 20586506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initial experience with routine administration of etanercept in psoriasis.
    de Groot M; Appelman M; Spuls PI; de Rie MA; Bos JD
    Br J Dermatol; 2006 Oct; 155(4):808-14. PubMed ID: 16965432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term etanercept use for severe generalized psoriasis in an HIV-infected individual: a case study.
    Lee ES; Heller MM; Kamangar F; Park KK; Koo JY
    J Drugs Dermatol; 2012 Mar; 11(3):413-4. PubMed ID: 22395596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Etanercept in a patient with severe psoriasis and latent viral hepatic disease and latent tuberculosis.
    Prestinari F; Ferguglia G; Laria G
    Am J Clin Dermatol; 2010; 11 Suppl 1():57-8. PubMed ID: 20586514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Managing pediatric patients with psoriasis.
    Bard S; Torchia D; Schachner LA
    Am J Clin Dermatol; 2010; 11 Suppl 1():15-7. PubMed ID: 20586500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of etanercept in children and adolescents aged > or = 8 years with severe plaque psoriasis.
    Landells I; Paller AS; Pariser D; Kricorian G; Foehl J; Molta C; Freundlich B
    Eur J Dermatol; 2010; 20(3):323-8. PubMed ID: 20185386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Onset of lichen planus during treatment with etanercept.
    Musumeci ML; Lacarrubba F; Micali G
    Am J Clin Dermatol; 2010; 11 Suppl 1():55-6. PubMed ID: 20586513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psoriasis and hepatitis C treated with anti-TNF alpha therapy (etanercept).
    Cecchi R; Bartoli L
    Dermatol Online J; 2006 Dec; 12(7):4. PubMed ID: 17459290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Retrospective study of etanercept use in elderly people with psoriasis].
    Ruiz-Villaverde R; Sanchez-Cano D; Abalos-Medina GM
    Rev Esp Geriatr Gerontol; 2010; 45(1):56-7. PubMed ID: 19939506
    [No Abstract]   [Full Text] [Related]  

  • 13. Study of etanercept, a tumor necrosis factor-alpha inhibitor, in recurrent ovarian cancer.
    Madhusudan S; Muthuramalingam SR; Braybrooke JP; Wilner S; Kaur K; Han C; Hoare S; Balkwill F; Ganesan TS
    J Clin Oncol; 2005 Sep; 23(25):5950-9. PubMed ID: 16135466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Etanercept for psoriasis: two case reports.
    Fidalgo A; Baptista J; Rocha Páris F; Caldas Lopes L; Ferreira A
    Int J Clin Pharmacol Res; 2005; 25(4):159-63. PubMed ID: 16402631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe psoriasis pustulosa palmaris et plantaris (Barber-Königsbeck) treated successfully with soluble tumour necrosis factor receptor fusion protein (etanercept).
    Kasche A; Pfab F; Hein R; Athanasiadis GI; Ollert M; Ring J; Eberlein-König B
    J Eur Acad Dermatol Venereol; 2007 Feb; 21(2):255-7. PubMed ID: 17243968
    [No Abstract]   [Full Text] [Related]  

  • 16. Rapid response of nail psoriasis to etanercept.
    Rallis E; Stavropoulou E; Rigopoulos D; Verros C
    J Rheumatol; 2008 Mar; 35(3):544-5. PubMed ID: 18322982
    [No Abstract]   [Full Text] [Related]  

  • 17. Nodular fasciitis: a possible side effect of etanercept?
    Vine K; Dacko A; Weinberg JM
    Cutis; 2013 Oct; 92(4):199-202. PubMed ID: 24195093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A patient with psoriasis and vitiligo treated with etanercept.
    Campanati A; Giuliodori K; Ganzetti G; Liberati G; Offidani AM
    Am J Clin Dermatol; 2010; 11 Suppl 1():46-8. PubMed ID: 20586509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of severe psoriasis with an apparent incomplete response to anti-tumour necrosis factor alpha treatment.
    Agnusdei CP; Mastronardi C
    Am J Clin Dermatol; 2010; 11 Suppl 1():41-3. PubMed ID: 20586507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Etanercept in infants: suberythrodermic, recalcitrant psoriasis in a 22 month-old child successfully treated with etanercept.
    Fabrizi G; Guerriero C; Pagliarello C
    Eur J Dermatol; 2007; 17(3):245. PubMed ID: 17478389
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.